We are live on ! Find out more
ADIM

Alpha DNA Investment Management Portfolio holdings

AUM $8.98M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+12.81%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$283M
AUM Growth
+$162M
Cap. Flow
+$72.6M
Cap. Flow %
25.66%
Top 10 Hldgs %
42.53%
Holding
215
New
70
Increased
65
Reduced
14
Closed
66

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$2.38M
2
WMT icon
Walmart Inc
WMT
+$2.38M
3
JPM icon
JPMorgan Chase
JPM
+$2.13M
4
FATE icon
Fate Therapeutics
FATE
+$1.92M
5
FTNT icon
Fortinet
FTNT
+$1.5M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$2.05M
2
PFE icon
Pfizer
PFE
+$1.44M
3
CVS icon
CVS Health
CVS
+$1.41M
4
MET icon
MetLife
MET
+$1.4M
5
DE icon
Deere & Co
DE
+$1.24M

Sector Composition

Rank Sector Weight
1 Financials 18.71%
2 Technology 15.05%
3 Industrials 8.12%
4 Healthcare 7.38%
5 Energy 5.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
H icon
101
Hyatt Hotels
H
$16.3B
$1.06M 0.37%
+11,686
New +$1.07M
PNFP icon
102
Pinnacle Financial Partners Inc
PNFP
$16B
$1.06M 0.37%
+14,397
New +$1.16M
PFE icon
103
Pfizer
PFE
$152B
$1.06M 0.37%
20,611
-29,972
-59% -$1.44M
NBR icon
104
Nabors Industries
NBR
$1.3B
$1.05M 0.37%
+6,809
New +$1.02M
HWC icon
105
Hancock Whitney
HWC
$6.28B
$1.05M 0.37%
+21,789
New +$1.13M
BANR icon
106
Banner Corp
BANR
$2.47B
$1.05M 0.37%
16,657
+7,064
+74% +$474K
UAL icon
107
United Airlines
UAL
$41B
$1.05M 0.37%
+27,920
New +$1.13M
CFR icon
108
Cullen/Frost Bankers
CFR
$10.3B
$1.05M 0.37%
7,869
+3,433
+77% +$488K
PFBC icon
109
Preferred Bank
PFBC
$1.27B
$1.05M 0.37%
+14,097
New +$1.03M
TRMK icon
110
Trustmark
TRMK
$2.78B
$1.05M 0.37%
+30,129
New +$1.05M
BOKF icon
111
BOK Financial
BOKF
$8.75B
$1.05M 0.37%
+10,094
New +$1.02M
OI icon
112
O-I Glass
OI
$1.1B
$1.05M 0.37%
+63,092
New +$1.02M
ACN icon
113
Accenture
ACN
$110B
$1.04M 0.37%
3,912
-667
-15% -$184K
CHEF icon
114
Chefs' Warehouse
CHEF
$4.46B
$1.04M 0.37%
+31,304
New +$1.09M
TXRH icon
115
Texas Roadhouse
TXRH
$13.8B
$1.04M 0.37%
+11,451
New +$1.1M
ARCC icon
116
Ares Capital
ARCC
$14.3B
$1.04M 0.37%
+56,288
New +$1.06M
FIVE icon
117
Five Below
FIVE
$13B
$1.03M 0.36%
+5,832
New +$917K
FATE icon
118
Fate Therapeutics
FATE
$319M
$1.03M 0.36%
+102,094
New +$1.92M
OZK icon
119
Bank OZK
OZK
$5.66B
$1.03M 0.36%
25,681
+12,767
+99% +$548K
LKFN icon
120
Lakeland Financial Corp
LKFN
$1.54B
$1.03M 0.36%
14,094
+7,579
+116% +$580K
TSLX icon
121
Sixth Street Specialty
TSLX
$1.78B
$1.03M 0.36%
+57,743
New +$1.04M
WABC icon
122
Westamerica Bancorp
WABC
$1.36B
$1.03M 0.36%
+17,374
New +$1.02M
HTGC icon
123
Hercules Capital
HTGC
$3.12B
$1.02M 0.36%
+77,251
New +$1.05M
HFWA icon
124
Heritage Financial
HFWA
$1.21B
$1.02M 0.36%
+33,322
New +$1.04M
DNOW icon
125
DNOW Inc
DNOW
$3.01B
$1.02M 0.36%
+79,994
New +$969K
3 4
5
6 7

Similar funds

CAWM
Capital A Wealth Management New Castle, Pennsylvania $8.94M AUM
AI
Allostery Investments Stamford, Connecticut $7.85M AUM
PC
Prysm Capital Princeton, New Jersey $10.6M AUM 2.38% 1-Year Est. Return
CP
Castalian Partners Excelsior, Minnesota $7.36M AUM
AVM
Altos Ventures Management Burlingame, California $11.7M AUM 182.72% 1-Year Est. Return
CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
NP
Newlight Partners New York $3.9M AUM 96.05% 1-Year Est. Return
BPWM
Black Point Wealth Management Naples, Florida $3.5M AUM 16.42% 1-Year Est. Return

Alpha DNA Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, Alpha DNA Investment Management held 215 positions worth $283M, up 135% from $120M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Alpha DNA Investment Management deployed $72.6M of net new capital in Q4 2022, opening 70 new positions and adding to 65 existing holdings. Its largest new stake was Fate Therapeutics: 102,094 shares worth $1.03M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was ExxonMobil, an estimated $2.05M trimmed.

  • Alpha DNA Investment Management's largest Q4 2022 buy was Fate Therapeutics: 102,094 shares worth $1.03M.
  • Alpha DNA Investment Management added most to McDonald's in Q4 2022, an estimated $2.38M increase.
  • Alpha DNA Investment Management's biggest Q4 2022 reduction was ExxonMobil, cutting an estimated $2.05M.
  • Alpha DNA Investment Management fully exited CVS Health in Q4 2022, selling an estimated $1.41M.
  • Alpha DNA Investment Management's ten largest holdings make up 43% of its $283M portfolio in Q4 2022.
  • Alpha DNA Investment Management opened 70 new positions and closed 66 in Q4 2022.
  • Alpha DNA Investment Management's portfolio value rose 135% quarter-over-quarter to $283M.

Based on Alpha DNA Investment Management's 13F filing for Q4 2022, filed 27 Jan 2023.